Brind.

PROCEPT BioRobotics conducted procedures in Scottsdale as part of an FDA investigational device exemption trial.

1 report, 1 independent Updated Jul 23

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

PROCEPT BioRobotics FDA

Keep exploring

The entities involved

PROCEPT BioRobotics
Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Jul 23GlobeNewswireAmbulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasda